This is a preview of subscription content, log in via an institution to check access.
Reference
Tay LJ, et al. Cost effectiveness of sacral neuromodulation and OnabotulinumtoxinA in managing refractory idiopathic overactive bladder. Urology : 20 Nov 2020. Available from: URL: http://doi.org/10.1016/j.urology.2020.11.018
Rights and permissions
About this article
Cite this article
Sacral neuromodulation vs botulinum toxin A in refractory idiopathic overactive bladder: review of cost-effectiveness evidence. PharmacoEcon Outcomes News 868, 27 (2020). https://doi.org/10.1007/s40274-020-7359-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7359-3